Trial · NCT07883733
Comparing Spinal, Epidural, and Dural Puncture Epidural Anesthesia for Cesarean Delivery: Hemodynamics and Block Quality
NCT07883733, Not applicable, Not yet recruiting, Bursa Yuksek Ihtisas Training and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparing Spinal, Epidural, and Dural Puncture Epidural Anesthesia for Cesarean Delivery: Hemodynamics and Block Quality. Trials, record NCT07883733. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883733
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparing Spinal, Epidural, and Dural Puncture Epidural Anesthesia for Cesarean Delivery: Hemodynamics and Block Quality
- NCT number
- NCT07883733
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Conditions
- Hypotension After Neuraxial Anesthesia, Cesarean Section, Anesthesia, Obstetrical, Post-Dural Puncture Headache
- Interventions
- Spinal Anesthesia, Epidural Anesthesia, Dural Puncture Epidural Anesthesia
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Maternal Hypotension | From completion of the neuraxial block (time 0) until the end of surgery (approximately 90 minutes) | Proportion of participants who develop at least one episode of hypotension, defined as a decrease in mean arterial pressure of more than 20% from baseline or systolic blood pressure below 90 mmHg. Baseline values are recorded before the neuraxial block. Blood pressure will be measured non-invasively every 3 minutes for the first 20 minutes after completion of the block and every 5 minutes thereafter until the end of surgery. |
| Secondary | Number of Hypotension Episodes | From completion of the neuraxial block until the end of surgery (approximately 90 minutes) | Number of hypotension episodes per participant (count), using the same definition as the primary outcome. |
| Secondary | Total Ephedrine Consumption | From completion of the neuraxial block until the end of surgery (approximately 90 minutes) | Total dose of intravenous ephedrine administered to treat hypotension, in milligrams (mg). |
| Secondary | Shock Index | Baseline (before the block), every 3 minutes for the first 20 minutes after completion of the block, and every 5 minutes thereafter until the end of surgery (approximately 90 minutes) | Ratio of heart rate to systolic blood pressure (unitless ratio). |
| Secondary | Diastolic Shock Index | Baseline (before the block), every 3 minutes for the first 20 minutes after completion of the block, and every 5 minutes thereafter until the end of surgery (approximately 90 minutes) | Ratio of heart rate to diastolic blood pressure (unitless ratio) |
| Secondary | Time to T6 Sensory Block | From completion of the neuraxial block until bilateral T6 sensory block is achieved | Time from the end of local anesthetic injection to bilateral T6 sensory block, assessed by pin-prick and cold tests, in minutes. |
| Secondary | Umbilical Cord Blood pH | At delivery | pH of umbilical cord blood measured by blood gas analysis (pH units). |
| Secondary | Incidence of Post-Dural Puncture Headache | Postoperative 24 hours and postoperative day 3 | Proportion of participants with post-dural puncture headache, assessed in the hospital at postoperative 24 hours and by telephone on postoperative day 3. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883733
GET https://conductscience.org/api/trials/v1/NCT07883733/registered